fda tirzepatide update today BREAKING NEWS!!! A weight loss drug more effective than Semaglutide has been approved by the today. (Zepbound for weight loss and Mounjaro for diabetes) showed a 15-20.9% weight change in Lilly's weight-loss drug removed from

Food and Drug Administration (FDA) about the potential risk for thyroid C-cell tumors

PlexusDx does not require insurance, and the medication is HSA/FSA eligible

The drug is still in the clinical trial phase

It can cause symptoms such as anemia, abdominal pain, weight loss, constipation, diarrhea and the presence of blood or mucus in the stool

Sam Altman has officially been reinstated atop OpenAI as CEO 'I have never been more excited about the future,' says Altman Sam Altman confirmed on Wednesday that he was returning to the helm at OpenAI as CEO, nearly two weeks after he was ousted from the company he co-founded

I ignored it, thinking I was imagining it because I was nervous about the vaccine in the first place